Enterome

Enterome is a biotech company in Paris, France, founded in 2011. It has raised $19.0M across 6 rounds, most recently a $19.0M Series E in June 2025.

Delivering the promise of cancer immunotherapy

Headquarters
Paris
Founded
2011
Total Funding
$19.0M
Last Round
$19.0M Series EJun 2025
Rounds
6

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 6 funding rounds and 5 investors for this company. The full record is or through the API.

About

Enterome is a clinical-stage company developing off-the-shelf, transformational cancer treatments targeting a wide range of tumor types, including glioblastoma, adrenal tumors, non-Hodgkin lymphoma, and colorectal cancer. Phase 2 trials of its programs, EO2463, EO4010, and EO2401, have shown promising efficacy with good safety profiles in over 240 patients. The company's OncoMimics approach generates a powerful, long-lasting immune response from a patient's own effector memory T cells, effectively overcoming immune tolerance to self-antigens.

Summary

It has raised $19.0M in total across 6 rounds, most recently a $19.0M Series E round in Jun 2025. Investors include Seventure Partners, Lundbeckfond Ventures and SymBiosis II.

Tech & App Stack

7 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series ESeries EJun 2025
$19.0M

Sign up to see all 6 events

Funding: Series A through Series E. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Enterome on Indexed.vc
<a href="https://indexed.vc/companies/enterome"><img src="https://indexed.vc/api/badge/company/enterome" alt="Enterome on Indexed.vc" width="260" height="76" /></a>